NEW
Stock Screener with Intrinsic Value
United Therapeutics Corporation (UTHR)
Last Price$365.0(0.4%)
Market Cap$16.2B
25.0%
Peers median - 14.5%
32.6%
Peers median - 0.6%
6.6%
Peers median - 10.1%
70.4%
Peers median - (18.0%)
Competing with UTHR
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare UTHR Valuation Multiples with Peers
Crunching data... Almost there!
Compare UTHR Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does United Therapeutics Corporation (UTHR) revenue growth compare to peers and the industry?
United Therapeutics Corporation (UTHR) revenue growth is 25.0%, compared to the peers' median of 14.5%.
2. How does United Therapeutics Corporation (UTHR) Free Cash Flow (FCF) margin compare to peers and the industry?
United Therapeutics Corporation (UTHR) FCF margin is 32.6%, compared to the peers' median of 0.6%.
3. How does United Therapeutics Corporation (UTHR) Total Debt to Equity ratio compare to peers and the industry?
United Therapeutics Corporation (UTHR) Total Debt to Equity ratio is 6.6%, compared to the peers' median of 10.1%.
4. How does United Therapeutics Corporation (UTHR) ROIC (Return on Invested Capital) compare to peers and the industry?
United Therapeutics Corporation (UTHR) ROIC is 70.4%, compared to the peers' median of (18.0%).